Navigation Links
US Oncology Announces Retirement of R. Dale Ross and Appointment of Bruce Broussard as Chairman of the Board
Date:8/5/2009

THE WOODLANDS, Texas, Aug. 5 /PRNewswire/ -- Today, the Board of Directors of US Oncology Holdings, Inc. and its wholly owned subsidiary, US Oncology, Inc. (collectively, "US Oncology" or the "Company"), announced that, effective Sept. 1, 2009, R. Dale Ross is retiring as Executive Chairman and from the Board of Directors. At that time, Bruce Broussard, the Company's CEO and President, will also become Chairman of the Board.

"Almost seventeen years ago, I founded US Oncology with the mission of increasing access to and advancing the delivery of high-quality cancer care in America," said Ross. "Over the course of those years, US Oncology has refined and enhanced its strong practice management expertise, particularly in the community setting, while developing robust clinical expertise and expanding to offer a wide range of services, resources and tools spanning the entire cancer care delivery system nationwide. Today, US Oncology's mission is to enable physicians to provide the right treatment, at the right time, for the right patient, and the Company is well positioned for success in the future. Now is the appropriate time for me to retire and to turn over full leadership of the Company to Bruce Broussard. Bruce has done an outstanding job since becoming the CEO in February 2008, and I have tremendous confidence in his ability, dedication and integrity. Even though I am retiring, I will continue to be a large stockholder of the Company, and fully and enthusiastically support Bruce, the management team and the Company in achieving its mission."

Broussard joined US Oncology in August 2000 as its Chief Financial Officer, assumed responsibility of the Pharmacy division in September 2003, was appointed President in November 2005 and became CEO in February 2008. In his new role as Chairman of the Board, Broussard will retain his positions as CEO and President. Broussard stated, "It has been a privilege to w
'/>"/>

SOURCE US Oncology Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
2. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
3. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
4. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
5. US Oncology to Report 2007 Third Quarter Earnings Results
6. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
7. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
8. Varian Medical Systems Ranks First in Overall Service Performance in 2007 Survey of U.S. Radiation Oncology Professionals
9. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
10. Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology
11. National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National Greening Your School Initiative

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., WASHINGTON, Dec. 1 In...are more likely than those with traditional covera..., to be more engaged in wellness programs, and to ...s matter in holding down costs, according to surve...ee Benefit Research Institute (EBRI). ,, At th...
(Date:12/1/2009)..., PHOENIX, Dec. 1 Abrazo Media R...nd Scoliosis ( http:// www.pedsorthopaedics.com ) ... orthopaedic surgeon Dr. J. Hunt Udall to its prac...ne and orthopaedic surgery after recently completi...n Boston, Massachusetts where he focused on adult ...
(Date:12/1/2009)..., FORT LAUDERDALE, Fla., Dec. 1 O...t enrollment in the randomized clinical trial of t...ombo Stent). ,, A prospective, randomized, mult...ion of an ablu M inal sirolimus coat ED bio- ...at up to 20 sites in Asia, Australia, Europe and S...
(Date:12/1/2009)... 1, 2009) The ADEAGies Foundation will honor The ...Award at the Gies Awards celebration to be held on...ion with the 2010 ADEA Annual Session & Exhibition...n, and Achievement recognize contributions to, and...atives. For a complete listing of Gies Award winne...
(Date:12/1/2009)... patients in California are unable to successfully... at hospitals despite recent state legislation int...a new study. , Posing as low-income uninsured pa...less than one-third of the hospitals they approach...er than those allowed under California law, accord...
Breaking Medicine News(10 mins):Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:Orthopaedic Surgeon Dr. J. Hunt Udall Joins the Center for Pediatric Orthopaedics and Scoliosis as One of Few Trained Doctors to Perform Minimally Invasive Hip Arthroscopy 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:The Forsyth Institute receives the William J. Gies Award for outstanding achievement 2Health News:Hospital price transparancy laws in California fall short, study finds 2
...n as physical disability does, study shows , ...ssion stops stroke victims from returning to work ...alian researchers report. , The study of 210 men a...a recent U.S. study, said researchers at the Georg...
...ion Diagnostics,LLC, the premier provider of compr... medication monitoring, and support services natio...hensive website. The new site, http://www.dominion...omer services and create a centralized location of...
...,(Nasdaq: BLUD ), a global leader in providing au...ansfusion industry, today announced that it expect..., April 1, 2008, after the,close of regular tradin...his conference call, with Dr. Gioacchino De,Chiric...
...sdaq:,CRYO), reported today that its Annual Report...ing concern" qualification. The going-concern,qual...t registered public,accounting firm expressing sub...ional working capital. In its Annual,Report on For...
... under review by U.S. agency and manufacturer Merc...-- The U.S. Food and Drug Administration said Thur...creased risk of mood changes and suicidal behavior..., it posted sales of $4.3 billion, making it Merck...
...cells to their destination in the body , ,...em cell lab" created by U.S. researchers holds pro...applications, as well as in the design of certain ...ll. uses one polymer and one small molecule that i...
Other Medicine News:Health News:Depression After Stroke Can Be Debilitating 2Health News:Dominion Diagnostics Announces Launch of Comprehensive New Company Website 2Health News:Immucor Schedules Third Quarter Earnings Release and Conference Call 2Health News:CryoCor Reports Going Concern Statement and Receives Notification From Nasdaq Relating to Minimum Stockholders' Equity 2Health News:CryoCor Reports Going Concern Statement and Receives Notification From Nasdaq Relating to Minimum Stockholders' Equity 3Health News:FDA Probing Possible Link Between Asthma Drug and Suicide Risk 2Health News:FDA Probing Possible Link Between Asthma Drug and Suicide Risk 3Health News:Researchers Create Protective Sac for Growing Stem Cells 2
(Date:12/1/2009)..., , ARLINGTON, Va., Dec. 1 /PRNewswir... its newest report, The Market Outlook for Resea...appropriated to the NIH Scientific Research progra...RRA) is being earmarked for lab renovations, Chall...d research that spans multiple public and non-prof...
(Date:12/1/2009)..., , ATLANTA, Dec. 1 /PRNewswire-FirstCal...ogical medical device and cardiovascular tissue pr...guidance for 2010. ,, The Company expects total...$118.0 million and $123.0 million, which includes ...unding received from the Department of Defense in ...
(Date:12/1/2009)..., , CHICAGO, Dec. 1 A...ociety of North America (RSNA), Royal Philips Elec...al Breast Workspace, a set of solutions that provi...ity breast images at one workspot to help drive qu...o breast care, Philips will also highlight new cap...
Breaking Medicine Technology:BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 2BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 3CryoLife Provides Initial 2010 Financial Guidance 2CryoLife Provides Initial 2010 Financial Guidance 3CryoLife Provides Initial 2010 Financial Guidance 4CryoLife Provides Initial 2010 Financial Guidance 5Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 2Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 4Suicide Risk With Antidepressants Falls With Age 54272 1Suicide Risk With Antidepressants Falls With Age 54272 2Suicide Risk With Antidepressants Falls With Age 54272 3Caraco Pharmaceutical Laboratories Ltd Markets Generic Imitrex 28R 29 Tablets 54270 1Caraco Pharmaceutical Laboratories Ltd Markets Generic Imitrex 28R 29 Tablets 54270 2HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 1HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 2HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 3HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 4
...announced today at the American Diabetes Associati...ulin detemir [rDNA origin] injection) can,be used ...onse to insulin,glargine over a 24-hour period in ...rces that once-daily Levemir has a similar 24-hour...essor Allen B. King,Diabetes Care Center, Salinas,...
...ific Sessions, SAN FRANCISCO, June 7 Sanofi-aven...inding study for its new,injectable diabetes compo...e American Diabetes Association,s (ADA) 68th Annua...lifornia., The study found that AVE0010 was well ...rol versus placebo in type 2 diabetes patients,ina...
Other Medicine Technology:New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes 2New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes 3New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes 4New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study 2New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study 3New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study 4
AB-180 iVAD
Safeguard
Icy
PeriVac Pericardiocentesis Kit with 7F pigtail catheter
Medicine Products: